Robert Lentz

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    ALX Oncology
    Topic:
    Research funding to institution
    Date added:
    02/27/2024
    Date updated:
    02/27/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck
    Topic:
    Research funding to institution
    Date added:
    02/27/2024
    Date updated:
    02/27/2024
  • Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Lilly
    Topic:
    Research funding to institution
    Date added:
    02/27/2024
    Date updated:
    02/27/2024
  • Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Guardant
    Topic:
    Research funding to institution
    Date added:
    02/27/2024
    Date updated:
    02/27/2024
  • Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    EDDC
    Topic:
    Research funding to institution
    Date added:
    02/27/2024
    Date updated:
    02/27/2024
  • Type of financial relationship:
    Independent contractor
    Ineligible company:
    Boehringer Ingelheim
    Topic:
    Consultant
    Date added:
    02/27/2024
    Date updated:
    02/27/2024
  • Type of financial relationship:
    Independent contractor
    Ineligible company:
    Agenus
    Topic:
    Consultant
    Date added:
    02/27/2024
    Date updated:
    02/27/2024
  • Type of financial relationship:
    Independent contractor
    Ineligible company:
    Myeloid Therapeutics
    Topic:
    Consultant
    Date added:
    02/27/2024
    Date updated:
    02/27/2024
Return to Colorado Hematology Oncology Conference: Emphasis on Precision-Guided Management